Gemcitabine hydrochloride and Infusion related reaction - a phase IV clinical study of FDA data

Summary:

Infusion related reaction is reported as a side effect among people who take Gemcitabine hydrochloride (gemcitabine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Oxaliplatin, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Infusion related reaction when taking Gemcitabine hydrochloride. It is created by eHealthMe based on reports of 14,753 people who have side effects when taking Gemcitabine hydrochloride from the FDA, and is updated regularly.

What is Gemcitabine hydrochloride?

Gemcitabine hydrochloride has active ingredients of gemcitabine hydrochloride. eHealthMe is studying from 14,775 Gemcitabine hydrochloride users. Check the latest studies of Gemcitabine hydrochloride.

What is Infusion related reaction?

Infusion related reaction is found to be associated with 1,530 drugs and 1,354 conditions by eHealthMe. Check the latest studies of Infusion related reaction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14,753 people reported to have side effects when taking Gemcitabine hydrochloride.
Among them, 51 people (0.35%) have Infusion related reaction.

Could Gemcitabine hydrochloride cause Infusion related reaction?

Among these 51 people:

How long have people been on Gemcitabine hydrochloride when they have Infusion related reaction? *

What is the gender of people who have Infusion related reaction when taking Gemcitabine hydrochloride? *

female: 67.35 %
male: 32.65 %

What is the age of people who have Infusion related reaction when taking Gemcitabine hydrochloride? *

What are other drugs people take besides Gemcitabine hydrochloride? *

What are other side effects people have besides Infusion related reaction? *

Anaemia (lack of blood): 12 people, 23.53%
Nausea And Vomiting: 12 people, 23.53%
Dyspnea (difficult or laboured breathing): 11 people, 21.57%
Fatigue (feeling of tiredness): 10 people, 19.61%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 17.65%
Nausea (feeling of having an urge to vomit): 9 people, 17.65%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 7 people, 13.73%
Dizziness: 7 people, 13.73%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 6 people, 11.76%
Fever: 6 people, 11.76%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 9 people, 17.65%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 13.73%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 5 people, 9.80%
Pancreatic Carcinoma (pancreatic cancer): 3 people, 5.88%
Ovarian Cancer Metastatic (cancer of ovary spreads to other organ or parts): 3 people, 5.88%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 3.92%
Endometrial Cancer: 2 people, 3.92%
Sarcoma Metastatic (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues spreads to other parts): 2 people, 3.92%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 3.92%
Pain: 2 people, 3.92%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine hydrochloride and have Infusion related reaction?

- Check whether Infusion related reaction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemcitabine hydrochloride:

Gemcitabine hydrochloride (14,775 reports)

Browse all side effects of Gemcitabine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion related reaction:

Infusion related reaction (1,530 drugs)

Browse all the conditions that are associated with Infusion related reaction:

Infusion related reaction (1,354 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemcitabine hydrochloride) and Gemcitabine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.